Economic Evaluation of Breast Cancer Screening in China: A Systematic Review of Costs and Cost-Effectiveness

Key Points

• Breast cancer screening shows significant cost-effectiveness when integrated into China's healthcare policies.
• The analysis revealed a cost savings estimate of approximately 20% over 10 years for proactive screening measures.
• Systematic review of economic evaluations emphasizes the value of cost analysis in prioritizing health interventions.
• Supporting effective screening programs may lead to earlier detection, improving outcomes within budget constraints.